Xuan Bai Cheng Qi formula as an adjuvant treatment of acute exacerbation of chronic obstructive pulmonary disease of the syndrome type phlegm-heat obstructing the lungs: a multicenter, randomized, double-blind, placebo-controlled clinical trial

Clinical Trial ◽

Acute Exacerbation ◽

Adjuvant Treatment ◽

Chronic Obstructive ◽

Syndrome Type ◽

Double Blind ◽

A multicenter randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of rhubarb in treating acute exacerbation of chronic obstructive pulmonary disease of the syndrome type phlegm-heat obstructing the lungs

Journal of Traditional Chinese Medical Sciences ◽

10.1016/j.jtcms.2016.07.002 ◽

2016 ◽

Vol 3 (2) ◽

pp. 71-80

Author(s):

Fengjie Zheng ◽

Yan Sun ◽

Xianggen Zhong ◽

Yueqi Wang ◽

Ruohan Wu ◽

...

Keyword(s):

Pulmonary Disease ◽

Acute Exacerbation ◽

Controlled Trial ◽

Chronic Obstructive ◽

Syndrome Type ◽

Double Blind ◽

Safety And Efficacy ◽

The Adjunctive Effect of Intravenous Magnesium Sulfate in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial

Academic Emergency Medicine ◽

10.1111/acem.14050 ◽

2020 ◽

Author(s):

Elnaz Vafadar Moradi ◽

Elham Pishbin ◽

Seyed Reza Habibzadeh ◽

Morteza Talebi Doluee ◽

Azadeh Soltanifar

Keyword(s):

Clinical Trial ◽

Magnesium Sulfate ◽

Pulmonary Disease ◽

Acute Exacerbation ◽

Chronic Obstructive ◽

Randomized Controlled Clinical Trial ◽

Randomized Controlled

MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial

CrossRef Listing of Deleted DOIs ◽

10.1183/09031936.96.09071482 ◽

1996 ◽

Vol 9 (7) ◽

pp. 1482-1486 ◽

Cited By ~ 53

Author(s):

M. Luisetti ◽

C. Sturani ◽

D. Sella ◽

E. Madonini ◽

V. Galavotti ◽

...

Keyword(s):

Clinical Trial ◽

Pulmonary Disease ◽

Neutrophil Elastase ◽

Chronic Obstructive ◽

Neutrophil Elastase Inhibitor ◽

Double Blind ◽

Elastase Inhibitor

Faculty Opinions recommendation of Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718313352.793493922 ◽

2014 ◽

Author(s):

Mark Dransfield ◽

Michael Wells ◽

Surya Bhatt

Keyword(s):

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(14)70153-5 ◽

2014 ◽

Vol 2 (9) ◽

pp. 698-705 ◽

Cited By ~ 314

Author(s):

Thomas Köhnlein ◽

Wolfram Windisch ◽

Dieter Köhler ◽

Anna Drabik ◽

Jens Geiseler ◽

...

Keyword(s):

Clinical Trial ◽

Positive Pressure Ventilation ◽

Positive Pressure ◽

Chronic Obstructive ◽

Non Invasive ◽

Randomised Controlled Clinical Trial ◽

Randomised Controlled

Sugarcane bagasse dietary fiber as an adjuvant therapy for stable chronic obstructive pulmonary disease: a four-center, randomized, double-blind, placebo-controlled study

Journal of Traditional Chinese Medicine ◽

10.1016/s0254-6272(16)30057-7 ◽

2016 ◽

Vol 36 (4) ◽

pp. 418-426 ◽

Cited By ~ 1

Author(s):

Liu Miao ◽

Zheng Fengjie ◽

Ni Lei ◽

Sun Yan ◽

Wu Ruohan ◽

...

Keyword(s):

Adjuvant Therapy ◽

Dietary Fiber ◽

Pulmonary Disease ◽

Sugarcane Bagasse ◽

Controlled Study ◽

Chronic Obstructive ◽

Double Blind ◽

Supplemental dietary nitrate for chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled, crossover trial

Proceedings of The Nutrition Society ◽

10.1017/s0029665113001705 ◽

2013 ◽

Vol 72 (OCE3) ◽

Cited By ~ 1

Author(s):

C. P. Kerley ◽

K. Cahill ◽

K. Bolger ◽

K. Fennell ◽

A. O'Brien ◽

...

Keyword(s):

Pulmonary Disease ◽

Crossover Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Dietary Nitrate ◽

Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70200-5 ◽

2014 ◽

Vol 2 (1) ◽

pp. 63-72 ◽

Cited By ~ 51

Author(s):

Henrik Watz ◽

Helen Barnacle ◽

Benjamin F Hartley ◽

Robert Chan

Keyword(s):

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

P38 Mapk Inhibitor ◽

Mapk Inhibitor

Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70286-8 ◽

2014 ◽

Vol 2 (3) ◽

pp. 187-194 ◽

Cited By ~ 110

Author(s):

Jin-Ping Zheng ◽

Fu-Qiang Wen ◽

Chun-Xue Bai ◽

Huan-Ying Wan ◽

Jian Kang ◽

...

Keyword(s):

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Impact of vitamin D on spirometry findings and quality of life in patients with chronic obstructive pulmonary disease: a randomized, double-blinded, placebo-controlled clinical trial

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s207400 ◽

2019 ◽

Vol Volume 14 ◽

pp. 1495-1501 ◽

Cited By ~ 4

Author(s):

Ali Alavi Foumani ◽

Mojtaba Mehrdad ◽

Alireza Jafarinezhad ◽

Khadijeh Nokani ◽

Alireza Jafari

Keyword(s):

Quality Of Life ◽

Clinical Trial ◽

Vitamin D ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Double Blinded